{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T03:53:42Z","timestamp":1723002822199},"reference-count":13,"publisher":"Becaris Publishing Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>\n            <jats:bold>Aims:<\/jats:bold>\n            The RiGOR study's primary outcome measure was a 15% reduction in intraocular pressure (IOP) for patients with open-angle glaucoma at 1 year.\n            <jats:bold>Methods:<\/jats:bold>\n            Patients received treatment according to the ophthalmologist's usual practice.\n            <jats:bold>Results:<\/jats:bold>\n            A higher proportion of patients in the incisional and other surgery group achieved a 15% reduction in IOP than in the laser surgery or additional medication groups (82, 57, and 57% respectively). In multivariate regression analyses, incisional surgery patients were 2.7-times as likely as patients treated with additional medication to achieve a 15% reduction in IOP (odds ratio: 2.67; 95% CI: 2.01\u20133.57).\n            <jats:bold>Conclusion:<\/jats:bold>\n            Incisional and other surgical procedures are effective treatments. There were no differences in treatment response by race or ethnicity\n          <\/jats:p>","DOI":"10.2217\/cer.15.58","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T08:24:18Z","timestamp":1450772658000},"page":"87-98","source":"Crossref","is-referenced-by-count":5,"title":["Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study"],"prefix":"10.57264","volume":"5","author":[{"given":"Anne L","family":"Coleman","sequence":"first","affiliation":[{"name":"Jules Stein Eye Institute, David Geffen School of Medicine &amp; Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA"},{"name":"H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora C","family":"Lum","sequence":"additional","affiliation":[{"name":"H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Velentgas","sequence":"additional","affiliation":[{"name":"Outcome DEcIDE Center, Quintiles Real World &amp; Late Phase Research, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Su","sequence":"additional","affiliation":[{"name":"Outcome DEcIDE Center, Quintiles Real World &amp; Late Phase Research, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E","family":"Gliklich","sequence":"additional","affiliation":[{"name":"Massachusetts Eye &amp; Ear &amp; Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the RiGOR Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"unstructured":"Boland\n                                                                            MV Ervin\n                                                                            AM Friedman\n                                                                            D\n                                                                    Treatment for glaucoma: comparative effectiveness\n                                                                    . \n                                                                    Comparative Effectiveness Review No. 60 (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. HHSA 290\u20132007\u201310061\u2013I.) AHRQ Publication No 12\u2013EHC038\u2013EF Rockville MD USA. Agency for Healthcare Research and Quality 2012\n                                                                    . \n                                                                    www.effectivehealthcare.ahrq.gov\/reports\/final.cfm\n                                                                    .","key":"e_1_3_3_2_2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske MC","year":"2003","unstructured":"Leske MC , Heijl A , Hussein M Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial . Arch. Ophthalmol. 121 , 48 \u2013 56 ( 2003 ).","journal-title":"Arch. Ophthalmol."},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter PR","year":"2001","unstructured":"Lichter PR , Musch DC , Gillespie BW Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery . Ophthalmology 108 , 1943 \u2013 1953 ( 2001 ).","journal-title":"Ophthalmology"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","author":"The Advanced Glaucoma Intervention Study (AGIS): 7","year":"2000","unstructured":"The Advanced Glaucoma Intervention Study (AGIS): 7 . The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators . Am. J. Ophthalmol. 130 , 429 \u2013 440 ( 2000 ).","journal-title":"Am. J. Ophthalmol."},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","unstructured":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group . Am. J. Ophthalmol. 126 , 498 \u2013 505 ( 1998 ).","journal-title":"Am. J. Ophthalmol."},{"key":"e_1_3_3_7_2","first-page":"CD004399","article-title":"Medical versus surgical interventions for open angle glaucoma","volume":"9","author":"Burr J","year":"2012","unstructured":"Burr J , Azuara-Blanco A , Avenell A , Tuulonen A . Medical versus surgical interventions for open angle glaucoma . Cochrane Database Syst. Rev. 9 , CD004399 ( 2012 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_3_8_2","first-page":"1403","article-title":"The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group","volume":"97","year":"1990","unstructured":"The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group . Ophthalmology 97 , 1403 \u2013 1413 ( 1990 ).","journal-title":"Ophthalmology"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","article-title":"A twenty-year follow-up study of trabeculectomy: risk factors and outcomes","volume":"119","author":"Landers J","year":"2012","unstructured":"Landers J , Martin K , Sarkies N A twenty-year follow-up study of trabeculectomy: risk factors and outcomes . Ophthalmology 119 , 694 \u2013 702 ( 2012 ).","journal-title":"Ophthalmology"},{"key":"e_1_3_3_10_2","first-page":"CD006132","article-title":"Interventions for improving adherence to ocular hypotensive therapy","volume":"4","author":"Waterman H","year":"2013","unstructured":"Waterman H , Evans JR , Gray TA Interventions for improving adherence to ocular hypotensive therapy . Cochrane Database Syst. Rev. 4 , CD006132 ( 2013 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajo.2013.03.005","article-title":"The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population","volume":"156","author":"Ung C","year":"2013","unstructured":"Ung C , Murakami Y , Zhang E The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population . Am. J. Ophthalmol. 156 , 362 \u2013 369 ( 2013 ).","journal-title":"Am. J. Ophthalmol."},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ophtha.2003.09.025","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results","volume":"111","author":"Ederer F","year":"2004","unstructured":"Ederer F , Gaasterland DA , Dally LG The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results . Ophthalmology 111 , 651 \u2013 664 ( 2004 ).","journal-title":"Ophthalmology"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamaophthalmol.2015.57","article-title":"Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010","volume":"133","author":"Olayanju JA","year":"2015","unstructured":"Olayanju JA , Hassan MB , Hodge DO , Khanna CL . Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010 . JAMA Ophthalmol. 133 , 574 \u2013 580 ( 2015 ).","journal-title":"JAMA Ophthalmol."},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajo.2012.10.017","article-title":"Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS)","volume":"155","author":"Zahid S","year":"2013","unstructured":"Zahid S , Musch DC , Niziol LM , Lichter PR . Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS) . Am. J. Ophthalmol. 155 , 674 \u2013 680 ( 2013 ).","journal-title":"Am. J. Ophthalmol."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.2217\/cer.15.58","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T12:34:05Z","timestamp":1679229245000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.2217\/cer.15.58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.2217\/cer.15.58"],"URL":"https:\/\/doi.org\/10.2217\/cer.15.58","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"type":"print","value":"2042-6305"},{"type":"electronic","value":"2042-6313"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}